Jiangsu Apon Medical Technology Co Ltd Class A (300753) — Capital Reinvestment Ratio

Latest as of December 2024: 0.11x

Jiangsu Apon Medical Technology Co Ltd Class A (300753) has a Capital Reinvestment Ratio of 0.11x as of December 2024, meaning it reinvests 0% of its operating cash flow (CN¥49.02 Million) in capital expenditures (CN¥5.48 Million). See free cash flow generation of Jiangsu Apon Medical Technology Co Ltd C to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.11x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥49.02 Million
CNY

Capital Expenditures

CN¥5.48 Million
CNY

Data as of

Dec 2024
Most recent filing

Jiangsu Apon Medical Technology Co Ltd Class A Capital Reinvestment Ratio (2014–2024)

This chart tracks Jiangsu Apon Medical Technology Co Ltd Class A's Capital Reinvestment Ratio across 9 annual periods.

Annual Capital Reinvestment Ratio for Jiangsu Apon Medical Technology Co Ltd Class A (2014–2024)

Year-by-year Capital Reinvestment Ratio for Jiangsu Apon Medical Technology Co Ltd Class A from 2014 to 2024. For live market cap and broader valuation context, see how much is Jiangsu Apon Medical Technology Co Ltd C worth.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 0.65x CN¥15.68 Million CN¥10.23 Million ▼ -69.9%
2021 2.17x CN¥18.29 Million CN¥39.60 Million ▲ +406.5%
2020 0.43x CN¥83.34 Million CN¥35.64 Million ▼ -43.1%
2019 0.75x CN¥77.59 Million CN¥58.33 Million ▼ -4.6%
2018 0.79x CN¥78.13 Million CN¥61.59 Million ▲ +237.5%
2017 0.23x CN¥67.08 Million CN¥15.66 Million ▲ +229.1%
2016 0.07x CN¥60.97 Million CN¥4.33 Million ▼ -12.8%
2015 0.08x CN¥38.08 Million CN¥3.10 Million ▲ +2.4%
2014 0.08x CN¥33.49 Million CN¥2.66 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow